How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes

European Neuropsychopharmacology

Volumn 17, Issue 9, 2007, Pages 587-594

  Artioli, Paola ^a,b   Lorenzi, Cristina ^a,b   Pirovano, Adele ^a,b   Serretti, Alessandro ^a,b   Benedetti, Francesco ^a,b   Catalano, Marco ^a,b   Smeraldi, Enrico ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b Istituto Nazionale di Neuroscienze'   (Italy)

Author keywords

Antidepressants; Circadian rhythms; Depressive symptomatology; Mood disorders; Period 3 gene; Temperament and Character Inventory

Indexed keywords

FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FEMALE; GENE; GENETIC VARIABILITY; HPER3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; ONSET AGE; PERIOD 3 GENE; PHENOTYPE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TEMPERAMENT;

ADULT; AGE OF ONSET; CHRONOBIOLOGY DISORDERS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; PHENOTYPE; TEMPERAMENT; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 34447515196     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.03.004     Document Type: Article

References (69)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (1994), American Psychiatric Association, Washington DC
2. Amsterdam J.D., Fawcett J., Quitkin F.M., Reimherr F.W., Rosenbaum J.F., Michelson D., Hornig-Rohan M., and Beasley C.M. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. Am. J. Psychiatry 154 (1997) 963-969
3. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. suicidal behavior. Mol. Psychiatry 8 (2003) 654-663
4. Archer S.N., Robilliard D.L., Skene D.J., Smits M., Williams A., Arendt J., and von Schantz M. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26 (2003) 413-415
5. Benedetti F., Barbini B., Colombo C., Campori E., and Smeraldi E. Infradian mood fluctuations during a major depressive episode. J. Affect. Disord. 41 (1996) 81-87
6. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., and Smeraldi E. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet. 123B (2003) 23-26
7. Benedetti F., Pontiggia A., Bernasconi A., Colombo C., Florita M., and Smeraldi E. Lormetazepam in depressive insomnia: new evidence of phase-response effects of benzodiazepines. Int. Clin. Psychopharmacol. 19 (2004) 311-317
8. Caci H., Robert P., and Boyer P. Novelty seekers and impulsive subjects are low in morningness. Eur. Psychiatr. 19 (2004) 79-84
9. Chelminski I., Ferraro F.R., Petros T.V., and Plaud J.J. An analysis of the "eveningness-morningness" dimension in "depressive" college students. J. Affect. Disord. 52 (1999) 19-29
10. Cloninger C.R., Przybeck T.R., Svrakic D.M., and Wetzel R.D. The Temperament and Character Inventory (TCI): A Guide to its Development and Use (1994), Center for Psychobiology of Personality Washington University, St.Louis, Missouri
11. Collier D., Stöber G., Li T., Heils A., Catalano M., Di Bella D., Arranz M., Murray R., Vallada H., Bengel D., Müller-Reible C., Roberts G., Smeraldi E., Kirov G., Sham P., and Lesh P. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol. Psychiatry 1 (1996) 453-460
12. Cuellar A.K., Johnson S.L., and Winters R. Distinctions between bipolar and unipolar depression. Clin. Psychol. Rev. 25 (2005) 307-339
13. Cusin C., Serretti A., Lattuada E., Lilli R., Lorenzi C., Mandelli L., Pisati E., and Smeraldi E. Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders. J. Psychiatr. Res. 35 (2001) 217-223
14. Dunlap J.C. Molecular bases for circadian clocks. Cell 96 (1999) 271-290
15. Ebisawa T., Uchiyama M., Kajimura N., Mishima K., Kamei Y., Katoh M., Watanabe T., Sekimoto M., Shibui K., Kim K., Kudo Y., Ozeki Y., Sugishita M., Toyoshima R., Inoue Y., Yamada N., Nagase T., Ozaki N., Ohara O., Ishida N., Okawa M., Takahashi K., and Yamauchi T. Association of structural polymorphisms in the human period 3 gene with delayed sleep phase syndrome. EMBO Rep. 2 (2001) 342-346
16. El-Mallakh R.S. Lithium. Conn. Med. 54 (1990) 115-126
17. El-Mallakh S. Litihum: Actions and Mechanisms (1996), American Psychiatric Press, Washington, DC
18. Fahndrich E. Biological predictors of success of antidepressant drug therapy. Psychiatr. Dev. 5 (1987) 151-171
19. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., Bottlender R., Schule C., Zwanzger P., Engel R.R., Rupprecht R., Bondy B., Reiser M., and Moller H.J. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch. Gen. Psychiatry 61 (2004) 177-183
20. Glazier A.M., Nadeau J.H., and Aitman T.J. Finding genes that underlie complex traits. Science 298 (2002) 2345-2349
21. Goodwin F., and Jamison K. Manic-Depressive Illness (1990), Oxford University Press, New York
22. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
23. Hammoumi S., Payen A., Favre J.D., Balmes J.L., Benard J.Y., Husson M., Ferrand J.P., Martin J.P., and Daoust M. Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence?. Alcohol 17 (1999) 107-112
24. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., and Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 297 (2002) 400-403
25. Hastings M.H. Circadian clocks. Curr. Biol. 7 (1997) R670-R672
26. Holmes A., Murphy D.L., and Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161 (2002) 160-167
27. Ishikawa H., Ohtsuki T., Ishiguro H., Yamakawa-Kobayashi K., Endo K., Lin Y.L., Yanagi H., Tsuchiya S., Kawata K., Hamaguchi H., and Arinami T. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomark. Prev. 8 (1999) 831-833
28. Katzenberg D., Young T., Finn L., Lin L., King D.P., Takahashi J.S., and Mignot E. A CLOCK polymorphism associated with human diurnal preference. Sleep 21 (1998) 569-576
29. Kendler K.S. "A gene for...": the nature of gene action in psychiatric disorders. Am. J. Psychiatry 162 (2005) 1243-1252
30. Kent L., Doerry U., Hardy E., Parmar R., Gingell K., Hawi Z., Kirley A., Lowe N., Fitzgerald M., Gill M., and Craddock N. Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol. Psychiatry 7 (2002) 908-912
31. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., and Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch. Gen. Psychiatry 39 (1982) 879-883
32. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
33. Lotrich F.E., and Pollock B.G. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr. Genet. 14 (2004) 121-129
34. Lowrey P.L., and Takahashi J.S. Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu. Rev. Genet. 34 (2000) 533-562
35. Lucca A., Lucini V., Catalano M., Alfano M., and Smeraldi E. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. Neuropsychobiology 29 (1994) 108-111
36. Matsushita S., Nakamura T., Nishiguchi N., and Higuchi S. Association of serotonin transporter regulatory region polymorphism and abnormal eating behaviors. Mol. Psychiatry 7 (2002) 538-540
37. Mundo E., Walker M., Cate T., Macciardi F., and Kennedy J.L. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder. Arch. Gen. Psychiatry 58 (2001) 539-544
38. Nelsen M.R., and Dunner D.L. Clinical and differential diagnostic aspects of treatment-resistant depression. J. Psychiatr. Res. 29 (1995) 43-50
39. Nesse R.M. Is depression an adaptation?. Arch. Gen. Psychiatry 57 (2000) 14-20
40. Neumeister A., Konstantinidis A., Stastny J., Schwarz M.J., Vitouch O., Willeit M., Praschak-Rieder N., Zach J., de Zwaan M., Bondy B., Ackenheil M., and Kasper S. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch. Gen. Psychiatry 59 (2002) 613-620
41. Nowak J., and Januszkiewicz-Lewandowska D. Genetic determination of smell. Otolaryngol. Pol. 55 (2001) 575-579
42. Quitkin F.M., Rabkin J.G., Ross D., and Stewart J.W. Identification of true drug response to antidepressants. Use of pattern analysis. Arch. Gen. Psychiatry 41 (1984) 782-786
43. Quitkin F.M., Rabkin J.D., Markowitz J.M., Stewart J.W., McGrath P.J., and Harrison W. Use of pattern analysis to identify true drug response. A replication. Arch. Gen. Psychiatry 44 (1987) 259-264
44. Rausch J.L., Johnson M.E., Fei Y.-J., Li J.Q., Shendarkar N., Mac Hobby H., Ganapathy V., and Leibach F.H. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol. Psychiatry 51 (2002) 723-732
45. Reinink E., Bouhuys A.L., Gordijn M.C., and Van Den Hoofdakker R.H. Prediction of the antidepressant response to total sleep deprivation of depressed patients: longitudinal versus single day assessment of diurnal mood variation. Biol. Psychiatry 34 (1993) 471-481
46. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
47. Rousseva A., Henry C., Van Den Bulke D., Fournier G., Laplanche J.L., Leboyer M., Bellivier F., Aubry J.M., Baud P., Boucherie M., Buresi C., Ferrero F., and Malafosse A. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J. 3 (2003) 101-104
48. Schinka J.A., Busch R.M., and Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol. Psychiatry 9 (2004) 197-202
49. Sen S., Burmeister M., and Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am. J. Med. Genet. 127B (2004) 90-93
50. Serretti A., and Artioli P. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology 174 (2004) 490-503
51. Serretti A., Cusin C., Lattuada E., Di Bella D., Catalano M., and Smeraldi E. Serotonin Transporter Gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol. Psychiatry 4 (1999) 280-283
52. Serretti A., Zanardi R., Rossini D., Cusin C., Lilli R., and Smeraldi E. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol. Psychiatry 6 (2001) 586-592
53. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., and Smeraldi E. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am. J. Med. Genet. 121B (2003) 39-43
54. Serretti A., Cusin C., Benedetti F., Mandelli L., Pirovano A., Zanardi R., Colombo C., and Smeraldi E. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 10 (2005) 10
55. Serretti A., Mandelli L., Lorenzi C., and Smeraldi E. Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects. Psychiatry Res. 134 (2005) 191-194
56. Smeraldi E., Zanardi R., Benedetti F., Dibella D., Perez J., and Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry 3 (1998) 508-511
57. Smeraldi E., Benedetti F., and Zanardi R. Serotonin transporter promoter genotype and illness recurrence in mood disorders. Eur. Neuropsychopharmacol. 12 (2002) 73-75
58. Szekely A., Ronai Z., Nemoda Z., Kolmann G., Gervai J., and Sasvari-Szekely M. Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am. J. Med. Genet. 126B (2004) 106-110
59. Tome M.B., Cloninger C.R., Watson J.P., and Isaac M.T. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J. Affect. Disord. 44 (1997) 101-109
60. Wehr T.A., and Wirz-Justice A. Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria 15 (1982) 31-39
61. Wehr T.A., Wirz-Justice A., Goodwin F.K., Duncan W., and Gillin J.C. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 206 (1979) 710-713
62. Weissman M.M., and Bothwell S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 33 (1976) 1111-1115
63. Wever R.A. Phase shifts of human circadian rhythms due to shifts of artificial Zeitgebers [The 25-hour man. Results of a study on circadian rhythms in man]. Chronobiologia 7 (1980) 303-327
64. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., Kuhn C.M., Lewis J.G., Schanberg S.M., Stafford-Smith M., Suarez E.C., Clary G.L., Svenson I.K., and Siegler I.C. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 28 (2003) 533-541
65. Wirz-Justice A., Puhringer W., and Hole G. Sleep deprivation and clomipramine in endogenous depression. Lancet 2 (1976) 912
66. Wirz-Justice A., Benedetti F., Berger M., Lam R.W., Martiny K., Terman M., and Wu J.C. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol. Med. 35 (2005) 939-944
67. Zanardi R., Benedetti F., DiBella D., Catalano M., and Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene. J. Clin. Psychopharmacol. 20 (2000) 105-107
68. Zhao J.H., and Sham P.C. Faster allelic association analysis using unrelated subjects. Hum. Hered. 53 (2002) 36-41
69. Zylka M.J., Shearman L.P., Weaver D.R., and Reppert S.M. Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 20 (1998) 1103-1110